CHMP5 and COVID-19: To test this hypothesis we chose the Adenovector/antigen combination of a replication incompetent human Adenovirus serotype 26, the same used for the approved anti-COVID-19 vaccines INN- Ad26.COV2-S, encoding for the full length Sars-Cov2 Spike glycoprotein (Ad26-Spike).